Top 50 Medical Angel Investors in United Kingdom in May 2026
Top 50 Medical Angel Investors in United Kingdom in May 2026
| Investor | Medical United Kingdom investments |
|---|---|
| Jonathan Milner | 12 |
| Mark Bamforth | 3 |
| Ian Hogarth | 3 |
| Will Martin | 2 |
| Alexander Chesterman | 2 |
| Ariel Poler | 2 |
| Will Brooks | 2 |
| Matt Clifford | 2 |
| Matt Robinson | 2 |
| Taavet Hinrikus | 2 |
| Michael Pennington | 2 |
| Bashar Hamood | 1 |
| Jonathan Lenson | 1 |
| Errol Damelin | 1 |
| Bob Davis | 1 |
| Thomas Dyrberg | 1 |
| John Lloyd | 1 |
| Flavien Kulawik | 1 |
| Pa Nolan | 1 |
| Arthur Chen | 1 |
| Emilio Püschmann | 1 |
| Nicolaus Henke | 1 |
| John Taysom | 1 |
| Peer Schatz | 1 |
| Will Armitage | 1 |
| Brendan O'Driscoll | 1 |
| Sidar Sahin | 1 |
| Andrew MacKay | 1 |
| Elan Katz | 1 |
| Henry Carleton | 1 |
| Sachin Agrawal | 1 |
| David Prior | 1 |
| Johnathan Matlock | 1 |
| Jim Mellon | 1 |
| Brian Kennedy | 1 |
| Carlos Ballarati | 1 |
| Yusuf Hamied | 1 |
| Brian Souter | 1 |
| Anand Mahindra | 1 |
| Jim Mellon | 1 |
| Inaki Berenguer | 1 |
| Alex Macdonald | 1 |
| Charlotte Scott | 1 |
| Phil Kirby | 1 |
| Robert Marshall | 1 |
| Andre Crawford-Brunt | 1 |
| Simon Franks | 1 |
| Evan Cheng | 1 |
| Jag Singh | 1 |
| John Spearman | 1 |
Reach every investor
Get a list of investors who already back your industry, stage, and country. Emails & phones included.
Find investors — It's Free!Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Series B
- United Kingdom, United States, Spain
Portfolio highlights
- Nuclera — Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered totake control of biology through streamlined access to a next-day supply of proteins and genes.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
- Constructive Bio — We place non-canonical amino acids at precise positions in proteins and peptides to create therapeutics with new properties, then manufacture them through fermentation.
Mark Bamforth is the Operating Partner at Ampersand Capital Partners.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Funding Round, Seed
- United Kingdom, United States
Portfolio highlights
- Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
- PneumoWave — PneumoWave is developing real-time monitoring solutions to allow patients with respiratory conditions and their doctors to track their respiratory rates and performance out of hospital, at home and at work. Combining proprietary sensor technology and an innovative AI driven digital therapeutic software platform, PneumoWave's technologyenables doctors to rationalise medication use, identify early signs of deterioration, reduce or shorten hospital admissions and reduce face to face appointments.
- Thymmune Therapeutics — Thymmune Therapeutics is developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.
Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.
Show more...Investment focus
- Software, E-Commerce, Medical
- Seed, Pre-Seed, Series A
- United Kingdom, United States, Germany
Portfolio highlights
- Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
- Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
- Fabric — Fabric is an AI-powered workspace and file manager for people and groups.Fabric is a self-organizing multiplayer workspace.
Will Martin - Founder and Director @ Portfolio Ventures
Show more...Investment focus
- Financial Services, Software, FinTech
- Seed, Funding Round, Series A
- United Kingdom, Japan, United States
Portfolio highlights
- Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
- Loadsure — Loadsure is a spot freight cargo insurance company.
- Marshmallow — Digital-first car insurance company with a mission to deliver great prices, service, and coverage.
Alex Chesterman is the Co-Founder of Houseful. Alex Chesterman attended the University College London.
Show more...Investment focus
- FinTech, E-Commerce, Financial Services
- Seed, Pre-Seed, Series A
- United Kingdom, France
Portfolio highlights
- Zefir — Zefir aims to expand the realm of possibilities for millions of European homeowners. We make home-selling simpler, faster and more certain by buying the property directly from you. Selling a home is now just a few clicks away.
- Pharmacierge — Pharmacierge is the digital e-prescribing service chosen by private clinicians to deliver medication to their patients throughout the UK and worldwide. Clinicians create and transfer e-prescriptions to our pharmacy near London's Harley Street, for free delivery to their patients either the same day or next weekday
- Vyne Technologies — Vyne Technologies is the specialist account-to-account payments platform.
Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.
Show more...Investment focus
- Software, Social Media, Internet
- Seed, Series A, Angel
- United States, Spain, Mexico
Portfolio highlights
- Goin — Goin is a mobile application to save money easily and take advantage of it without knowing how to invest, through Machine Learning algorithms that allow you to accumulate the user's money through small daily gestures. he three Spanish founders, David, Carlos and Gabriel, were looking for a way to optimize their own money, and decided toconduct an experiment by exchanging their debit cards and thus saving 62% during those two months of rehearsal. This is how Goin emerged, which aims to meet the needs of 100% of Millennials, of which 83% confess that they do not know how to save, making available an easy-to-use tool that enhances their finances and lifestyle. On the one hand, the Barcelona startup allows the user to add money automatically and multiply it without having previous knowledge of investment. Goin uses a simple system that first asks to know the user through questions about their habits and, in this way, they are offered automatic systems and methods of saving. Once the user adds money to the app, they can transfer part or all of it to investment, or to their bank account. Its Smart Saving technology manages to accumulate money with small, everyday gestures, such as rounding a payment.
- Kiwibot — Delivery robots to optimize your business and deliver safely and timely to your customers.
- Grin Scooters — Grin Scooters is a software company that operates network of operational shared electric scooters. Currently, Grin only operates in Mexico City, Guadalajara, Monterrey, Sao Paulo and Bogota but it has plans to expand to other cities throughout Latin America.
Will Brooks - Founder & Director @ Portfolio Ventures
Show more...Investment focus
- FinTech, Financial Services, Software
- Seed, Funding Round, Series A
- United Kingdom, United States
Portfolio highlights
- Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
- Robin — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
- Marshmallow — Digital-first car insurance company with a mission to deliver great prices, service, and coverage.
Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.
Show more...Investment focus
- Software, FinTech, Artificial Intelligence
- Seed, Pre-Seed, Funding Round
- United Kingdom, United States, India
Portfolio highlights
- Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
- Koos — KOOS is a simple legal and technological solution for motivating and rewarding your community. Boost your growth by sharing success.
- Asymmetric Security — Asymmetric Security is an AI-native cybersecurity startup specializing in digital forensics and incident response. It combines elite forensic experts with proprietary AI to accelerate investigations, especially Business Email Compromise (BEC) attacks, at less than half the cost of competitors while shrinking timelines from days to hours.
Matt Robinson is the CEO and a co-founder at Nested, a property technology company. Prior to this, he founded GoCardless in 2010 and remains on the board of the recurring payment company.
Show more...Investment focus
- Software, FinTech, Financial Services
- Seed, Series A, Pre-Seed
- United Kingdom, United States, Germany
Portfolio highlights
- Malga — Malga is an online payment platform that offers fraud protection and payment split services.
- Feather — Feather gives you insurance advice for expats in Germany. Our digital insurance agent will help you get the right insurance policies for your need.
- Malga — Instant access to multiple payment providers with a single integration
Taavet Hinrikus is based out of London, England and is the Partner of Plural Platform and Board Member of CoMind. Taavet previously worked at Wise as a Chairman and Co-founder. Taavet Hinrikus attended INSEAD.
Show more...Investment focus
- FinTech, Software, Financial Services
- Seed, Series A, Series B
- United Kingdom, United States, Estonia
Portfolio highlights
- Juro — Juro is an all-in-one contract automation platform that helps legal and business users to agree & manage contracts in one unified workspace.
- Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
- Skeleton Technologies — Skeleton Technologies is the global leader in ultracapacitor & supercapacitor energy storage and helps companies in automotive, transportation, grid, and industry to save energy.
One of the UK's leading tech angel investors. Active seed and pre-seed stage angel investor in UK based disruptive tech. Prefers businesses venturing into pastures new and keen investing at the pre product stage whether BtoC or B2B. Twice exited UK based tech entrepreneur with experience operating tech businesses in 20 countries in multiplelanguages. Co-founded Gumtree with Simon Crookall which was acquired by Ebay and Slando acquired by Naspers.
Show more...Investment focus
- Software, SaaS, FinTech
- Seed, Pre-Seed, Funding Round
- United Kingdom, United States, Spain
Portfolio highlights
- Hubflo — Hubflo is building an all-in-one work OS to help small businesses manage their business. Instead of having 10 complicated and expensive pieces of software, Hubflo offers SMB everything they need to run their business (CRM, projects, invoicing, expenses...) in a single comprehensive, simple and affordable platform.
- FUEL — Where everlasting fanbases are built
- Sidekick — Expertly-managed portfolios for the modern investor
Bashar Hamood is a Venture Partner at FasterCapital. He previously worked as an Associate Director at Logica. He attended Heriot-Watt University.
Show more...Investment focus
- Information Technology, Software, E-Commerce
- Seed, Pre-Seed, Series A
- United States, Nigeria, United Kingdom
Portfolio highlights
- Lawyeree — A platform offering AI legal advice to clients and allowing clients to be connected with the best lawyers.
- TravelTales — TravelTales is a platform that connects travelers with local guides who offer personalized.
- Mancano And Associates — Domain name Mancano.com exudes a sense of mystery and intrigue, with a versatile appeal that can cater to a wide range of startups. The names brevity, with only 7 letters, makes it easy to remember and type, ideal for establishing a strong
Jonathan Lenson
Show more...Investment focus
- Software, Information Technology, Internet
- Seed, Grant, Pre-Seed
- United Kingdom, Israel
Portfolio highlights
- Fertifa — Fertifa is an innovative employer benefit solution making fertility care more accessible and affordable.The company works with employers to offer a valuable employee benefit which bridges the gap between an employer and their employees when dealing with the sensitivity and privacy of employees’ reproductive issues. It also offers guidance andadvice, next-generation fertility treatment, and access to a range of holistic services for the best chance of success. The company was founded in 2019 and based in London, United Kingdom.
- Roleshare — Roleshare matches freelancers, part-time and fractional workers to job share; helping companies retain and attract coveted skills and talent. Join us!
- Surfboard — Get Dialpad Workforce Management (WFM) software for accurate forecasting, demand-driven scheduling, fair shift planning, and more.
Errol Damelin is the Founder, CEO, chairman, or original investor and backer of over 75 digital and tech companies around the world, including in the US, the UK, most of Europe, Israel, Indonesia, Brazil, Turkey, South Africa, and Nigeria. He concentrates his efforts on SaaS, fintech, crypto, marketplaces and data analytics as well as on health andwellness. He is also a technologist and has three granted patents to his name with another four pending.Among the companies co-founded by Damelin are groundbreaking fintech company Wonga, and SME banking startup Tide. His early investments include Wise, Cazoo, Purplebricks, K Health, YuLife, Sure, Demyst, Zoe, Farewill, CityMapper, Modifi, UnBabel, Thimble, HiBob, Modifi, Elliptic, Lendingkart, and VivaReal. Using his own personal equity, Damelin continues to invest early on in the next generation of entrepreneurs so that he can help them succeed. He is not an institutional VC fund and does not maximize the assets under his management. He best describes his approach as Riding Shotgun.Damelin's success as a founder has been recognized by The Guardian, which named him Digital Entrepreneur of the Year in 2011; by Ernst and Young, which named him the UK's Entrepreneur of the Year in 2011 as well; and by TechCrunch, which named him Founder of the Year in 2010.
Show more...Investment focus
- FinTech, Financial Services, Finance
- Seed, Series A, Pre-Seed
- United Kingdom, United States, Israel
Portfolio highlights
- Zelt — Manage everything from HRIS, payroll, pension, devices, apps and more seamlessly in one central hub, for all processes and applications, third-party included. Improve productivity through enhanced employee experience.
- Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
- OurRitual — Couple Goals Made Possible. Relationship Support For Busy People, Practical Tools & Expert Feedback
Bob Davis is a General Partner at Highland Capital Partners and an Executive Chairman at Highland Transcend Partners. He was a CEO at Lycos. Bob attended Northeastern University and Babson College.
Show more...Investment focus
- Internet, Advertising, Social Network
- Series A, Series B, Series C
- United States, United Kingdom
Portfolio highlights
- LovePop — Buy online, personalize, schedule and send 3D pop-up cards with free shipping. Lovepop has greeting cards & paper art for every occasion. A Lovepop is a beautiful keepsake that unfolds like a miniature surprise.
- TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
- Vecna Robotics — Vecna Robotics is the leading autonomous mobile robot (AMR) company that provides logistics automation and workflow optimization solutions.
Thomas P. Dyrberg, M.D., Ph.D., serves as Senior Partner of Novo Ventures and Novo A/S. Thomas Dyrberg joined Novo A/S in December 2000, where he was a Partner.He held research positions at the Hagedorn Research Institute, Gentofte, Denmark and at the Scripps Research Institute, La Jolla, California.In 1990, he joined Novo NordiskA/S and worked in health care discovery on various aspects of diabetes immunology and pathogenesis and health Care Clinical Drug Development as an International Clinical Project Manager since 1996. He serves as the Deputy Chairman of Veloxis Pharmaceuticals A/S and has been its Director since September 2003.Thomas Dyrberg has been a Director at Gloucester Pharmaceuticals, Inc. since August 25, 2009. He serves as a Director at Rejuvenon, Corp, Allocure Inc., Veloxis, Lux Biosciences, Inc., Ophthotech Corporation, Sapphire Therapeutics Inc., and Delenex Therapeutics AG.He served as a Director of BioMimetic Therapeutics, Inc. from May 2001 to June 21, 2007. He served as a Director of Helsinn Therapeutics (U.S.), Inc. He has published several articles within the fields of diabetes, immunology, and autoimmunity.Thomas Dyrberg has an M.D. degree in 1981 and his DM.Sc. degree from the University of Copenhagen in 1986.
Show more...Investment focus
- Biotechnology, Medical, Health Care
- Series B, Series C, Seed
- United States, United Kingdom, Switzerland
Portfolio highlights
- PanOptica — PanOptica is a biopharmaceutical company developing a topical eye drop for the treatment of eye diseases caused by abnormal or leaky blood vessels.
- Pangaea Data — Find & connect with more patients, at scale, for therapies, clinical trials and drug discovery studies.
- Freeline — A leading biotechnology company focused on innovative liver directed gene therapies for bleeding disorders and other debilitating, chronic diseases
John Lloyd
Show more...Investment focus
- Health Care, Wellness, Education
- Seed, Funding Round, Equity Crowdfunding
- United Kingdom
Portfolio highlights
- Thrive — Thrive Mental Wellbeing - Mental Health Services
- Easy Peasy — Get EasyPeasy parenting tips and activities, personalised for you and your 0-5 year old, from our playful community of parents and experts.
- Elemental Software — Elemental is a digital platform that connects patients health and social care professionals and community health & wellness providers.Health Professionals are able to generate digital social prescriptions for citizens with chronic health risks such as depression, social isolation, type 2 diabetes and obesity, connecting them with qualityassured providers who deliver community based interventions across the domains of exercise, diet/nutrition, social support and mental health.The software is designed as a multi-tenanted cloud service and so can be implemented rapidly. It is highly parameterised and can be customised to suit an individual organisation's functional requirements without compromising its technological core.
Flavien Kulawik
Show more...Investment focus
- Health Care, Artificial Intelligence, SaaS
- Seed, Funding Round, Series A
- France, United Kingdom
Portfolio highlights
- Adionics — Adionics provides advances ionic solutions such as lithium and iodide extraction, and salts separation.
- Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
- Scienta Lab — Redefining precision immunology
Pa Nolan
Show more...Investment focus
- Medical, Delivery, Shipping
- Seed, Funding Round
- Ireland, United Kingdom
Portfolio highlights
- SiSaf — SiSaf delivers on the promise of RNA therapeutics with Bio-Courier technology.
- Scurri — Scurri is next generation delivery management software that puts retailers back in control. Explore our delivery management software today.
Arthur Chen is a Managing Partner at Ameba Capital.
Show more...Investment focus
- Medical, Chemical, Software
- Seed, Series A, Funding Round
- United Kingdom
Portfolio highlights
- Porotech — All-in-One MicroLEDs for Everyone, Everywhere, Every Device Unleashing the Power of Light Our MicroLED technology revolutionises the way displays are manufactured, making microLED displays possible for everyone. Through our partnerships and dedicated R&D teams we develop new technologies and can succeed together with you. compare to the conventional LED Porotech is here for your every
- Pangaea Data — Find & connect with more patients, at scale, for therapies, clinical trials and drug discovery studies.
Emilio Püschmann
Show more...Investment focus
- Medical, Database, Consulting
- Pre-Seed
- United Kingdom
Portfolio highlights
- OPEN Health — OPEN Health is a healthcare agency that provides market access strategy, health economic modeling and meta-analysis patient engagement, patient-centered outcomes, real-world evidence and data analytics, medical affairs consultancy and strategy, publications planning and delivery, scientific, communications, learning and development.
Nicolaus Henke is a senior partner at McKinsey & Company, where he advises leading companies on how to improve decision making and performance through advanced analytics, artificial intelligence, and end-to-end data enabled transformations, and is the global leader of McKinsey Analytics, which has more than 2,000 dedicated analyticspractitioners and translators, where he oversees partnerships between McKinsey and the wider artificial intelligence, data, and computing ecosystem. Nicolaus is the chairman of QuantumBlack (acquired by McKinsey in 2015), a company operating at the intersection of strategy, technology, and design, and a member of McKinsey’s global board, the Shareholder’s Council. He helped found and is a member of the Board of Innovative Healthcare Delivery at Duke Medicine and serves on the Dean’s Advisory Council at Harvard’s Kennedy School. Nicolaus frequently speaks on big data, analytics, and healthcare topics at global forums such as the World Economic Forum, the Milken Institute, and Forbes. He holds a master’s degree and PhD in business from the University of Münster, Germany, and a master’s in public administration from Harvard University, where he was a John J. McCloy Scholar.
Show more...Investment focus
- Information Technology, SaaS, Medical
- Seed, Pre-Seed
- United Kingdom
Portfolio highlights
- seedata.io — Honeypots, but better! Seedata.io provides cloud-native deception technology to improve threat detection with AI-driven honeypots.
- Little Journey — Little Journey supports children and their families before, during and after healthcare interactions, reducing anxiety and improving health outcomes
- Oxford Medical Simulation — Drive clinical competency with OMS. Combining healthcare education and competency assessment with dynamic virtual reality simulations.
John Taysom started the Reuters Venture Capital Fund in Palo Alto in 1995 making 82 investments in internet and web infrastructure and services including Verisign, UltraDNS, Digimarc, ZeroKnowledge and Intertrust. He was a member of the Board of Digimarc pre and post its Nasdaq IPO, a Board member at Intertrust and a Board member at TIBCO throughits Nasdaq IPO. To date, seventeen of his investments have achieved an IPO.John acquired the Fund in an MBO in 2002. Now London-based with a seed portfolio of thirty US and UK start-ups; one has achieved an IPO and several have been acquired by Experian, Linkedin, Tesco, BMC and others.In 2011 and 2012 John took a Fellowship at Harvard to work on privacy issues and holds EU and US patents on a method of improving privacy online. For 2015 John is a Policy Fellow at the University of Cambridge Centre for Science and Policy and a Visiting Professor, Department of Computer Science, at UCL. He is a member of the Board of the Web Science Trust; chairs Performance Horizon, a fast growing UK startup; is a Governor at Hurstpierpoint College; and runs a small farm in Devon.
Show more...Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Angel, Series A
- United Kingdom, United States
Portfolio highlights
- LGN — LGN's edge AI management software puts you in complete technical and financial control of your edge AI systems.
- Tenyks — Tenyks gives Computer Vision Engineers the insights to build more reliable models faster! Collaborate to identify and fix dataset issues. Improve data quality. Boost model performance. No more wondering in the dark.
- Worldr — Valarian | Innovating for the new era of digital sovereignty
1989, Master's in Finance, Univ. of St Gallen, Switzerland; 1991, MBA in Finance, Graduate School of Business, Univ. of Chicago. Former: Partner, private management buy-out group, Switzerland; finance and systems positions, Sandoz and Computerland; finance, operations, management and sales positions, computer and software trading start-upcompanies, Europe, US. 1993, joined QIAGEN, when the company had just 30 employees and revenues of approximately $2 million. Former Member, German Corporate Governance Commission. Director: AdvaMedDx (US in-vitro diagnostics industry organization); ALDA (Analytical, Life Science & Diagnostics Association).
Show more...Investment focus
- Medical, Genetics, Health Care
- Seed
- United States, United Kingdom
Portfolio highlights
- Valar Labs — AI to Make Oncologists Smarter
- Relation Therapeutics — Relation uses machine learning to develop drugs for pressing unmet need.
William Armitage is the Co-Founder & CFO ,Advisor of The Game Day.
Show more...Investment focus
- FinTech, Software, Health Care
- Seed, Angel, Pre-Seed
- United Kingdom, Chile
Portfolio highlights
- Global 66 — Global 66 is an international online payment platform that allows customers to transfer money with rates up.
- Tallarium — Tallarium - The definitive pre-trade data and analytics platform for OTC energy markets, driven by data science
- Alphagreen Group — Alphagreen Group is a global acquisition and incubation platform with a health & wellness focus. We help brands to scale via our own distribution channels and an extensive external omni-channel network. Build: We build brands using our marketplace and other sources to inform us on consumer demand. We automate the sales of products acrossvarious eCommerce channels, from DTC, on Alphagreen.io, Amazon, affiliates and other channelsAcquire: We acquire high calibre profitable health and wellness brands. We use our data and network to qualify existing products to forecast future growth and automate the management of assets once acquiredScale: We scale brands using our expertise in growth hacking, existing tech infrastructure and an experienced team. Distribution includes via DTC, alphagreen.io and external marketplaces such as Amazon.
Brendan O'Driscoll is the Chief Product Officer of KOHO.
Show more...Investment focus
- Wellness, Health Care, Medical
- Seed, Pre-Seed, Series A
- United States, India, United Kingdom
Portfolio highlights
- Betterhalf — Best matrimony app in India with AI matchmaking. Get compatible life partner from lakhs of genuine, Govt ID and selfie verified profiles of brides & grooms. Download Betterhalf marriage app now!
- Betty Labs — Spotify is a digital music service that gives you access to millions of songs.
- Levels — Improve metabolic health with CGM, comprehensive labs, and a personalized plan.
Sidar Sahin is Founder & CEO at Peak Games.
Show more...Investment focus
- Medical, mHealth, Health Care
- Series A
- United Kingdom
Portfolio highlights
- Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.
Andrew MacKay
Show more...Investment focus
- Medical, Hospital, Health Care
- Seed
- United Kingdom
Portfolio highlights
- MyHealthPal — MyHealthPal is a health & wellbeing app to promote healthy living and help you manage your own or other people's health conditions.
- Materials Nexus — Accelerating change to net-zero materials
Elan Katz, CEO at Quick RX.
Show more...Investment focus
- Medical, Health Care, Medical Device
- Seed
- United Kingdom
Portfolio highlights
- TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
Henry is a trained doctor with extensive hospital experience who co-founded Four Eyes Insight to put his talent for finding strategic solutions and planning into helping the NHS.His interest in medical resource management developed during his junior doctor training at Bart’s and the Royal London and he helped trusts tackle the significantchallenges of rotas and the New Deal as Junior Doctors’ Advisor at the London Regional Action Team.Establishing Zircadian Ltd, a software development company focusing on a portfolio of solutions to help NHS organisations plan and organise their medical workforce more strategically and effectively in 2000, he sold it on 11 years later to Allocate with over 140 NHS clients using its products.
Show more...Investment focus
- Medical, Health Care, Health Diagnostics
- Series A
- United Kingdom
Portfolio highlights
- Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
Sachin Agrawal
Show more...Investment focus
- Medical, Health Care, Health Diagnostics
- Series A
- United Kingdom
Portfolio highlights
- Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
David Prior is the former chair of the UK's National Health Service.
Show more...Investment focus
- Health Care, Medical, Software
- Seed
- Belgium, United Kingdom
Portfolio highlights
- TORTUS AI — Innovative medical AI which revolutionises the healthcare industry by enhancing clinical operations and patient care. Book a free demo today.
- Awell Health — Ollie is a vast library of over 100 interface blocks with complete Webflow CMS integration. Build beautiful websites in less time than ever.
Johnathan Matlock is Co-Founder Science Angel Syndicate.
Show more...Investment focus
- Biotechnology, Medical, Health Care
- Seed, Pre-Seed, Funding Round
- United Kingdom
Portfolio highlights
- OutSee — We are well-versed in a variety of genomics, AI and cohort analysis techniques. We are also bioinformatics generalists and work with just about any ...
- EnsiliTech — EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals
- Halo Therapeutics — Halo Therapeutics is based in England. Develops safe pan coronavirus antiviral drugs for Covid-19 that can be administered by patients.
Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.
Show more...Investment focus
- Biotechnology, Health Care, Food and Beverage
- Series A, Seed, Funding Round
- United States, United Kingdom, Israel
Portfolio highlights
- Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
- Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
- The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Brian Kennedy
Show more...Investment focus
- Music, Medical, Commercial
- Angel, Funding Round
- United States, United Kingdom
Portfolio highlights
- Gigmor — Booking live music has never been this easy!
- Ryboquin — Ryboquin™ uses its expertise to turn under-developed intellectual property ideas into viable commercial realities. Founded in Scotland, Ryboquin Ltd is a privately held, virtual pharmaceutical company focused on commercialising patented technologies in the area of human cancer medicine.Founded in Scotland, Ryboquin is a privately held, virtualpharmaceutical company focused on commercializing patented technologies in the area of human cancer medicine.
Carlos Ballarati - Founding partner @ Consulta do Bem
Show more...Investment focus
- Medical, Database, Consulting
- Pre-Seed
- United Kingdom
Portfolio highlights
- OPEN Health — OPEN Health is a healthcare agency that provides market access strategy, health economic modeling and meta-analysis patient engagement, patient-centered outcomes, real-world evidence and data analytics, medical affairs consultancy and strategy, publications planning and delivery, scientific, communications, learning and development.
Yusuf Hamied is a Cambridge-educated Chemist and the Non-Executive Chairman of the Board of Directors at Cipla, a large generic pharmaceuticals company founded in 1935 by his father, Khwaja Abdul Hamied. Yusuf became a global celebrity for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatmentsand other drugs to treat poor people in the developing world. After completing his doctorate in 1960, Yusuf joined the family company and vowed to break the dominance of foreign multinationals over the Indian pharmaceutical market by developing cheap generic drugs. Yusuf helped persuade the Indian government to change Indian patent law in 1972, permitting medicines to be copied even if they were under international patent, as long as the process was not the same. The law transformed the Indian pharmaceutical industry, enabling his and other companies to grow by manufacturing generic drugs. In 2001 Yusuf convulsed the global healthcare industry by promising and then delivering a triple drug cocktail, Triomune, that helped fight against HIV and AIDS at prices far lower than those available internationally. Yusuf discusses his subsequent anger when, in 2005, the Indian government brought its patent laws in line with those of the developed world, prohibiting the copying of drugs patented after 1995 without a license and his resentment that he had thereafter “to go with a begging bowl to the multinationals” for licenses. This interview provides not only a personal perspective on how India’s third largest pharmaceutical firm was created, but contributes to the broad debates on the costs and benefits of intellectual property laws, particularly their impact on people who are denied life-saving drugs by their inability to pay for them. Working for Cipla as Managing Director for nearly 52 years, Yusuf was also the 28th richest Indian during one time. ‘CNN-IBN Indian of the year’ and one among the ’25 greatest global living legends’ were the titles that Yusuf won for his reign in the pharma world majorly for making medicines affordable to the poor. Yusuf was awarded with the civil honorary Padma Bhushan from then president APJ Abdul Kalam in the year 2005 for his fight against AIDS, which he often said was going to be as damaging to the society as a massive earthquake would be, if ignored. Yusuf earned his Bachelor's degree (1956), Master's degree (1957) and Ph.D. (1960) in Chemistry from University of Cambridge.
Show more...Investment focus
- Medical, Medical Device
- Seed
- United Kingdom
Portfolio highlights
- 1inhaler — 1inhaler operates as a developer of drug delivery device.
Sir Brian Souter is co-founder and Chairman of Stagecoach plc, having retired as Chief Executive in May 2013.Whilst he does not sit with the Souter Investments team in Edinburgh, Sir Brian is active in all investment decision making processes and sits on the boards of our European bus operators (PolskiBus.com and OnniBus.com) and New Zealandtransport group (InMotion).Sir Brian is currently the Vice-President of the Institute of Chartered Accountants of Scotland.
Show more...Investment focus
- Medical, Commercial, Health Care
- Funding Round
- United Kingdom
Portfolio highlights
- Ryboquin — Ryboquin™ uses its expertise to turn under-developed intellectual property ideas into viable commercial realities. Founded in Scotland, Ryboquin Ltd is a privately held, virtual pharmaceutical company focused on commercialising patented technologies in the area of human cancer medicine.Founded in Scotland, Ryboquin is a privately held, virtualpharmaceutical company focused on commercializing patented technologies in the area of human cancer medicine.
Graduate, Harvard Univ. and Harvard Business School. Chairman and Managing Director, Mahindra Group. Thought leader in Indian business. Serves on many industry confederations. Initiated the Nanhi Kali programme to provide free education to economically underprivileged girls in India. Co-Founder, Naandi Danone, India's largest safe drinkingwater provider to rural areas. Life Trustee, Board of Naandi Foundation, which provides meals to 1.3 million children daily. Co-Chair, World Economic Forum Annual Meeting 2009. Named among World’s 50 Greatest Leaders, Fortune Magazine (2014); named one of the top 25 most powerful business people in Asia, Fortune Magazine (2011).
Show more...Investment focus
- Education, Artificial Intelligence, Social Media
- Seed, Angel, Series A
- India, United States, United Kingdom
Portfolio highlights
- Agnikul — Agnikul Cosmos designs and manufactures orbital-class launch vehicles powered by 3D-printed engines. From custom payloads to affordable private launches, we make space access simple, scalable, and mission-focused.
- Harvested Robotics — Harvested Robotics is an ag-tech company that focuses on safeguarding farms from weeds and diseases by lasers, robotics, and AI technology.
- Genrobotics Medical & Mobility — India's top-rated gait trainer, G Gaiter! Our AI-powered, robot assisted gait trainer accelerates neurorehabilitation for faster recovery.
Jim Mellon
Show more...Investment focus
- Medical, Health Care, Pharmaceutical
- Series A, Funding Round
- United Kingdom
Portfolio highlights
- Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.
Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.
Show more...Investment focus
- Financial Services, FinTech, E-Commerce
- Seed, Angel, Pre-Seed
- Spain, United States, United Kingdom
Portfolio highlights
- Ukio — Artfully designed fully furnished apartments available for extended stays
- Paack — Find the ideal delivery solution to integrate into your e-commerce. We adapt to your business, providing your customers with an amazing experience.
- Openlytics — Openlytics is a visual analytics platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape thedirection of the product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.
Alex Macdonald is the Co-Founder and CEO of sequel - an investment platform on a mission to help athletes build a legacy for their families and the world. He previously Co-Founded Velocity Black, raised more than $40m in funding, and which was successfully exited to US Bank Capital One in 2023. He is a serial angel investor having invested in 50early stage startups and funds.
Show more...Investment focus
- Software, Artificial Intelligence, FinTech
- Pre-Seed, Seed, Series A
- United Kingdom, United States, France
Portfolio highlights
- Kalder — Kalder is a unified web3 brand loyalty platform for brands and creators to drive meaningful engagement, onboard new users, and reward superfan communities.
- Stelia — Stelia stands at the forefront of the AI infrastructure revolution and is driving the transition from Internet 2.0, designed for data movement, to Internet 3.0, designed for data mobility, enabling the seamless flow and processing of data across diverse environments. With its ground-breaking HyperBand platform, Stelia enables businesses toharness the full potential of AI. The company's mission is to become the backbone of the next generation of data mobility, empowering organizations across industries to accelerate innovation, optimize operations, and drive transformative growth. Stelia will be at the gravitational centre of the AI infrastructure ecosystem – a trusted partner and catalyst for change that brings together forward-thinking businesses, technology leaders, and industry experts to shape the future of AI. It was founded in 2021 and is located in London, United Kingdom.
- Fundably — Fundably - Get The Right UK Business Loan | Access £1k-£2m
Charlotte Scott
Show more...Investment focus
- Medical, Health Care, Pharmaceutical
- Seed
- United Kingdom
Phil founded Health Intelligence in 1996 and maintains a vital role in the company shaping strategy and innovation. After graduating from Keele with an MBA on the Health Executive Programme, Phil spent thirteen years in the NHS as a senior manager responsible for I.T., registration and screening functions. This experience from within the NHS andprivate sector has given him an in-depth understanding of how cross sector population-based solutions can help the NHS overcome key challenges.
Show more...Investment focus
- Medical, Hospital, Medical Device
- Seed
- United Kingdom
Portfolio highlights
- AI-Sight — AI Sight Limited delivers next-generation AI-powered diabetic eye screening to enhance accuracy, speed, and accessibility across healthcare systems
Robert Marshall is Executive Chairman of Martlet Capital.
Show more...Investment focus
- Medical, Health Care, Medical Device
- Seed
- United Kingdom
Portfolio highlights
- EDX Medical Group — EDX Medical Group provides innovative digital diagnostic products and services for cancer, cardiovascular disease, neurology, and infectious disease testing.
Andre Crawford-Brunt
Show more...Investment focus
- Medical, Software, Health Care
- Series A, Seed
- United Kingdom
Portfolio highlights
- PQShield — PQShield is focused on empowering organizations, industries, and nations, with the ultimate quantum-resistant hardware and software solutions
- Ultromics — Unlock the full potential of echocardiography with groundbreaking solution that simplifies echo reporting. Echo that is precise, fast and accurate.
- SpyBiotech — SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.The company's biotechnology platform develops bonding vaccines which are made from the proprietary protein superglue which is used to bond antigens to viruses and other particles to make vaccines, enabling medical institutions and research centerswith a new and modified technology to develop vaccines which give better results in lesser time.
Simon Franks is the founder and managing partner of Redbus Ventures and Chairman of the Franks Family Foundation. (www.thefff.org)
Show more...Investment focus
- FinTech, Payments, Health Care
- Seed, Pre-Seed, Series A
- United Kingdom, Australia, United States
Portfolio highlights
- 5Mins — 5Mins is the new microlearning platform that helps your employees build in-demand skills fast with AI-powered personalisation and advanced gamification.
- Oto Health — Take back control of your tinnitus with Oto, the app built by doctors that teaches you how to stop noticing the ringing using clinically proven techniques. Includes CBT, targeted mindfulness, and relaxation. 86% users experience benefits after just 1 month.
- Pharmacierge — Pharmacierge is the digital e-prescribing service chosen by private clinicians to deliver medication to their patients throughout the UK and worldwide. Clinicians create and transfer e-prescriptions to our pharmacy near London's Harley Street, for free delivery to their patients either the same day or next weekday
Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.
Show more...Investment focus
- Software, Artificial Intelligence, Biotechnology
- Seed, Pre-Seed, Funding Round
- United States, United Kingdom, Australia
Portfolio highlights
- Jarsy — Jarsy Inc offers a platform for global investment opportunities using stablecoins.
- PIN AI — PIN AI democratizes personal on-device intelligence for everyone; transform your digital footprints into your Personal Executive Assistant.
- Verida — The Verida Wallet is a mobile application that allows you to manage your decentralized identity and personal data. It provides a user-friendly interface for interacting with applications built on the Verida network.
Jag is one of Europe's most active angel investors, and is a Managing Partner at Angel Invest Ventures in Berlin. He's founded several companies (including two exits and a spectacular failure), and invested in over 100 startups over the last six years, including Spire (SPAC), Nutmeg (exit to JPM), Disperse, Eversend, Restack, and Anytype.He’s an ad-man at heart, and spent over a decade as a political strategist advising high-profile politicians, campaigns and corporations across the US and Europe. Jag is fluent in six languages, and can be found on Twitter via @JagSingh
Show more...Investment focus
- Software, FinTech, Artificial Intelligence
- Pre-Seed, Seed, Angel
- Germany, United Kingdom, United States
Portfolio highlights
- Anytype — An operating system for the new Internet
- Machinery Partner — Machinery Partner is a marketplace buying heavy machinery and equipment directly from manufacturers. Browse our range of construction and mining equipment.
- Lightning Reach — Lightning Reach is a financial support portal that makes it easy for people to find and apply for a wide range of personalised support in one place. This support can range from; charitable grants, local council schemes, help with bills and the cost of living crisis and benefits.
John Spearman - Founder & Former Chief Executive @ Classic FM
Show more...Investment focus
- TV, FinTech, Finance
- Series A, Seed, Pre-Seed
- United Kingdom
Portfolio highlights
- Neyber — Join Neyber today to help improve financial wellbeing and happiness in the workplace. Financial education, affordable loans, and savings and investments paid from your salary.
- Techspert — Connect to the world's leading experts and access high-quality precise knowledge fast. Easy scheduling. Dedicated project managers.
- Ampersand Health — We are a social purpose company founded by doctors and patients to improve the health and happiness of people with long term inflammatory conditions.
Contact investors today
Find who invests in your industry, stage, and country in 5 minutes.
Find investors — It's Free!